# Noom's GLP-1Rx Program Combines Medication With Behavioral Support for Weight Loss
Noom has launched GLP-1Rx, a medically supervised program that pairs glucagon-like peptide-1 medications with behavioral coaching to address weight management. The program represents a shift toward comprehensive care that treats both the biological and behavioral aspects of weight loss.
GLP-1 medications like semaglutide and tirzepatide have gained widespread attention for their effectiveness in reducing appetite and supporting weight loss. These drugs work by mimicking hormones that regulate blood sugar and hunger signals. However, medication alone has limitations. People often regain weight after stopping treatment, and adherence drops when users lack ongoing support.
Noom's approach integrates GLP-1 medication with its established behavioral health platform. Users receive personalized coaching, habit-tracking tools, and educational content designed to build sustainable lifestyle changes alongside pharmacological support. The program pairs medication with what Noom frames as a "hype friend" model, meaning practitioners provide encouragement and accountability throughout treatment.
The clinical backing matters here. Rather than offering GLP-1 prescriptions in isolation, Noom's platform includes assessment tools, progress monitoring, and behavioral interventions grounded in cognitive behavioral therapy principles. Users work with healthcare providers who monitor medication effectiveness and safety while coaches address eating patterns and lifestyle factors.
This hybrid approach addresses a real gap in weight management. Many telehealth platforms prescribe GLP-1 medications without behavioral support, leaving users without tools to maintain results long-term. Conversely, behavioral programs alone often prove insufficient for people with metabolic factors driving weight gain.
The program targets adults seeking sustained weight loss with personalized treatment plans rather than one-size-fits-all approaches. Customization extends to medication selection, dosing, and frequency based on individual health profiles and goals